F-group (family)
7529.1.1.1 Macro
Ligands and drugs
2,223
Member domains
1,208
with ligand contacts (≤ 4 Å)
54.3% of members
749
with DrugDomain annotations
33.7% of members
255
with a DrugBank compound
11.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7529.1.1.1 belongs to X-group 7529 Macro domain-like, which binds 9.2 ligand superclasses per 20 proteins, broader than 83% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02059 | AR6 | Adenosine-5-Diphosphoribose | 28 |
| DB09459 | TLA | L-tartaric acid | 11 |
| DB16833 | ADP | Adenosine disphosphate | 7 |
| DB03309 | NHE | N-cyclohexyltaurine | 6 |
| DB15686 | U08 | GS-441524 | 5 |
| DB00640 | ADN | Adenosine | 3 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 3 |
| DB14128 | NAD | Nadide | 3 |
| DB00131 | AMP | Adenosine phosphate | 2 |
| DB00356 | CLW | Chlorzoxazone | 2 |
| DB01774 | ADQ | Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester | 2 |
| DB03056 | 4PN | 4-Piperidino-Piperidine | 2 |
| DB03780 | AQO | 2-Aminoquinazolin-4(3h)-One | 2 |
| DB00145 | GLY | Glycine | 1 |
| DB00171 | ATP | ATP | 1 |
| DB00233 | BHA | Aminosalicylic acid | 1 |
| DB00339 | PZA | Pyrazinamide | 1 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 1 |
| DB02095 | ISN | Isatin | 1 |
| DB02134 | XAN | Xanthine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 160 |
| APR | ADENOSINE-5-DIPHOSPHORIBOSE | 106 |
| TFA | trifluoroacetic acid | 56 |
| AR6 | [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE | 40 |
| MGmetal | MAGNESIUM ION | 16 |
| NAmetal | SODIUM ION | 13 |
| TLA | L(+)-TARTARIC ACID | 11 |
| ZNmetal | ZINC ION | 11 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 8 |
| CAmetal | CALCIUM ION | 8 |
| JNT | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{S})-2,3,4,5-tetrakis(oxidanyl)pentyl] hydrogen phosphate | 7 |
| A1R | 5'-O-[(S)-{[(S)-{[(2R,3R,4S)-3,4-DIHYDROXYPYRROLIDIN-2-YL]METHOXY}(HYDROXY)PHOSPHORYL]OXY}(HYDROXY)PHOSPHORYL]ADENOSINE | 6 |
| NHE | 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID | 6 |
| U08 | (2~{R},3~{R},4~{S},5~{R})-2-(4-azanylpyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolane-2-carbonitrile | 5 |
| A1AL7 | 2-[(4P)-4-(4-{[(1S)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylpropyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-6-yl)-1H-pyrazol-1-yl]-N,N-dimethylacetamide | 4 |
| A2R | [(2R,3R,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3-HYDROXY-4-(PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]METHYL [(2R,3S,4R,5R)-3,4,5-TRIHYDROXYTETRAHYDROFURAN-2-YL]METHYL DIHYDROGEN DIPHOSPHATE | 4 |
| A3R | Adenosine Diphosphate (Hydroxymethyl)pyrrolidine monoalcohol | 4 |
| AUmetal | GOLD ION | 4 |
| S6Y | 6-(2-methylpropyl)-2-oxidanylidene-5~{H}-pyrimidine-4-carboxylic acid | 4 |
| TEV | 6-methyl-2-oxo-2,5-dihydropyrimidine-4-carboxylic acid | 4 |